Literature DB >> 2544769

Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas.

E Rothbauer1, K Mann, B Wiebecke, P Borlinghaus, R Lamerz, E Pratschke, H J Krämling, A Pfeiffer.   

Abstract

The epidermal growth factor (EGF) and alpha-tumor growth factor are mitogenic proteins which bind to the EGF-receptor and may play a role in carcinogenesis or tumor progression. Our study investigated whether colorectal carcinomas and adenomas express altered levels of EGF-receptors or overproduce EGF-like activity by comparing histologically normal mucosa to carcinomas resected from the same patients. EGF-receptors were characterized by radioligand binding studies. Carcinomas contained unchanged or decreased levels of EGF-receptors in 13/16 and moderately increased levels in 3/16 patients as compared to normal mucosa. Adenomas obtained from 2 patients with familial polyposis coli and from a third patient with a coincident carcinoma had similar numbers of EGF-receptors as normal mucosa. EGF-like growth factors, in contrast, were significantly elevated in carcinoma extracts as compared to extracts from normal mucosa of the same patients. Adenomas did not contain elevated levels of EGF-like activity. We conclude that increased expression of EGF-receptors is infrequent in colonic adenocarcinomas. Increased production of EGF-like growth factors may frequently occur but seems to be associated with tumor progression rather than with premalignant lesions as represented by adenomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544769     DOI: 10.1007/BF01719776

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  Binding assays for epidermal growth factor.

Authors:  G Carpenter
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

Review 2.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

4.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  Production of transforming growth factors by human colon cancer lines.

Authors:  R J Coffey; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

6.  Increased expression of the epidermal growth factor receptor on human colon carcinoma cells.

Authors:  S J Bradley; G Garfinkle; E Walker; R Salem; L B Chen; G Steele
Journal:  Arch Surg       Date:  1986-11

7.  Cell kinetic indicators of premalignant stages of colorectal cancer.

Authors:  H Bleiberg; M Buyse; P Galand
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

8.  Dominant inheritance of adenomatous colonic polyps and colorectal cancer.

Authors:  R W Burt; D T Bishop; L A Cannon; M A Dowdle; R G Lee; M H Skolnick
Journal:  N Engl J Med       Date:  1985-06-13       Impact factor: 91.245

9.  Secretion of transforming growth factors by primary human tumour cells.

Authors:  A W Hamburger; C P White; F E Dunn
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  8 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Low diacylglycerol values in colonic adenomas and colorectal cancer.

Authors:  G Sauter; A Nerlich; U Spengler; R Kopp; A Pfeiffer
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.

Authors:  Li Jiao; Liang Chen; Abeer Alsarraj; David Ramsey; Zhigang Duan; Hashem B El-Serag
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

5.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.

Authors:  S Tanaka; K Imanishi; M Yoshihara; K Haruma; K Sumii; G Kajiyama; S Akamatsu
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

6.  Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.

Authors:  C Liu; A Woo; M S Tsao
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.

Authors:  L Kaklamanis; K C Gatter; N Mortensen; A L Harris
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

8.  Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.

Authors:  P G Koenders; W H Peters; T Wobbes; L V Beex; F M Nagengast; T J Benraad
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.